Cancer Systems Biology Consortium (CSBC)
|
|
- Evelyn Manning
- 5 years ago
- Views:
Transcription
1 Cancer Systems Biology Consortium (CSBC) Shannon Hughes, Ph.D. Program Director, Tumor Metastasis Branch Division of Cancer Biology, NCI ITCR PI Teleconference; February 2, 2018
2 Systems Biology at NCI 10 years of the Integrative Cancer Biology Program (ICBP) program evaluation New Initiative - Cancer Systems Biology Consortium (CSBC) Approved March 2015 Three funding announcements issued: Research Centers (), Research Projects (), and Coordinating Center (U24) NCI Program Staff: Erin Wetzel, Dave Miller, Nas Zahir, Shannon Hughes, Jerry Li, Jennifer Couch, Dan Gallahan, Dinah Singer 2
3 Structure of the Cancer Systems Biology Consortium Initiative Coordinating Center U24 Research Center Research Project CSBC Steering Committee Collaborative Projects Working Groups Annual Meetings Outreach (Summer Program) CSBC s: PAR (next receipt date June 22, 2018) CSBC s: RFA-CA (closed) CSBC U24: RFA-CA (closed) 3
4 Current CSBC Portfolio 9 CSBC Research Centers (as of 5/1/17) 1 U24 CSBC/PS-ON Coordinating Center 14 Research Projects 8 Active Collaborative Research in Integrative Cancer Biology (PAR ) 6 CSBC Research Projects (PAR ) Also 5 Active Bridging the Gap Between Cancer Mechanism and Population Science Information on currently funded projects can be found at *** 4
5 Current CSBC / Award Portfolio (23 awards) Categories: Research Theme (2 Major/Minor) Experimental Approaches (2) Computational Approaches (2) For example: Research Theme 1. Tumor Heterogeneity 2. Metastasis 3. Cancer Therapeutics 4. Microenvironment 5. Tumor Immunology 6. Dormancy Research Theme Each Project/Center represented by 6 element vector Ex. MSKCC [ ] Experimental Approach Computational Approach Pairwise Hamming Distance calculated between grants 5
6 Current CSBC / Award Portfolio Edges are weights calculated from Hamming Distance Thicker/Darker line = high similarity Grouped by Research Theme Tumor Heterogeneity Metastasis Cancer Therapeutics Tumor Immune/Stroma Dormancy 6
7 Current CSBC / Award Portfolio Edges are weights calculated from Hamming Distance Thicker line = high similarity Grouped by Research Theme Colored by Experimental Method Genomics/Transcriptomics Proteomics/PPI Imaging Epigenetics Single-Cell Analysis Metabolomics 7
8 Current CSBC / Award Portfolio Edges are weights calculated from Hamming Distance Thicker line = high similarity Grouped by Research Theme Colored by Computational Approach ML/DL Approaches Network Inference/Statistical Ecological/Evolutionary Mechanistic (ODE, etc) 8
9 Example: Combating subclonal evolution of resistant cancer phenotypes Track tumor evolution to determine appropriate treatment options Modified from Brady et al. Nature Comm, Nov Andrea Bild City of Hope CSBC 9
10 Example: Combating subclonal evolution of resistant cancer phenotypes 1) Combination of bulk WGS, WES and targeted single-cell DNA Seq to determine what mutations (subclones) are present in the tumor Dot = mutation Collection of dots = subclone 2) Over time, use single-cell RNASeq to determine which pathways are active in particular clones Modified from Brady et al. Nature Comm, Nov Andrea Bild City of Hope CSBC 10
11 PanCK CD3 CD4 CD8 FoxP3 Non-small cell lung cancer (NSCLC) Slide courtesy of Vivek Mittal Weill Cornell, CSBC
12 Identify key components Stromal cells (Paracrine) or Tumor cells (Autocrine) Differentially upregulated Ligands Expressed Receptors Tumor cells Expressed Transcription Factors/Differentially Expressed Target genes CCCExplorer Algorithm for Crosstalk Signaling Discovery paracrine Ligand-Receptor interactions Downstream signaling pathways G(V,E): signaling pathway V L : up-regulated ligand list V R : expressed receptor list V TF : activated TF list V T :up-regulated target gene list Distance Matrix Combine activated signaling branches autocrine Identify activated signaling pathways as a directed graph V L V R V i Distance 0 Distance 1 Distance 2 V j V TF V T Activated signaling branches (p<0.05) wwww.synapse.org/ CSBCPSON Slide modified from Stephen Wong Methodist Hospital CSBC
13 Ash Alizadeh Stanford CSBC 13
14 Using systems biology to probe tumor-immune interactions and mechanisms of immunotherapy 14
15 Knowledge Portal: gateway to CSBC/PS-ON activities Knowledge Portal Website
16 Building the CSBC/PS-ON Knowledge Portal Exposes and provides access to research activities and resources across Centers and Projects Serves as central gateway for scientific community to discover and utilize consortium material Community CSBC/PS-ON Knowledge Portal R O U24 C Slide care of Justin Guinney, Sage Bionetworks: CSBC/PS-ON Coordinating Center
17 CSBC/PS-ON Summer Undergraduate Research Program Applications are due February 16,
18 November 7-10, 2018 Woods Hole, MA Organized by AECCSB & NCI Scientific Co-chairs: Sylvia Plevritis, Stanford University Sandy Anderson, Moffitt Cancer Center Doug Lauffenburger, MIT See speaker line-up: Travel support will be available for select abstracts. for updates 18
19 Association of Early Career Cancer Systems Biologists (AECCSB) Purpose: Build a cancer systems biology community starting from scientists trained as part of the Integrative Cancer Biology Program. Help ESIs grow a network of like-minded scientists and promote advances by young investigators in the field (aameyer@ucla.edu) (stephen.piccolo.byu@gmail.com)
20 @NCISysBio
Systems Biology and Mathematical Oncology at the National Cancer Institute
Systems Biology and Mathematical Oncology at the National Cancer Institute Shannon Hughes, Ph.D. Division of Cancer Biology 240-276-6180 shannon.hughes@nih.gov April 28, 2017 The National Institutes of
More informationGrand Challenge and other funding opportunities at Cancer Research UK. Jamie Meredith, 9 th Dec 15
Grand Challenge and other funding opportunities at Cancer Research UK Jamie Meredith, 9 th Dec 15 Multidisciplinary research at CRUK OVERVIEW About CRUK CRUKs research strategy A focus on multidisciplinary
More informationNCI Cancer Moonshot. Christine Siemon National Cancer Institute, NIH. November 30, 2017
NCI Cancer Moonshot Christine Siemon National Cancer Institute, NIH November 30, 2017 Presidential Memo 2016 Overall Goals of the Cancer Moonshot Accelerate progress in cancer, including prevention & screening
More informationNCCIH s New Approach to Funding Clinical Trials Informational Webinar. April 18, 2017
NCCIH s New Approach to Funding Clinical Trials Informational Webinar April 18, 2017 Introductions Wendy Weber, N.D., Ph.D., M.P.H., Branch Chief, Clinical Research in Complementary and Integrative Health
More informationHow Systems Biology Can Advance Immune Oncology. Birgit Schoeberl, PhD NEDMG Summer Symposium May 31st
How Systems Biology Can Advance Immune Oncology Birgit Schoeberl, PhD NEDMG Summer Symposium May 31st Immuno-Oncology is One of the Most Promising Avenues in the Battle Against Cancer Conventional Therapy
More informationCANCER RESEARCH UK SPONSORSHIP OPPORTUNITIES
CANCER RESEARCH UK SPONSORSHIP OPPORTUNITIES Cancers of Unmet Need: Our Ambition Over the last 40 years, improvements in prevention, detection and treatment have revolutionised cancer medicine and survival
More informationSpontaneous canine malignancies: Models for precision cancer medicine
National Cancer Institute Spontaneous canine malignancies: Models for precision cancer medicine Amy K. LeBlanc, DVM DACVIM (Oncology) Director, NCI Comparative Oncology Program NIH/NCI Center for Cancer
More informationSheila Prindiville, MD, MPH Director Coordinating Center for Clinical Trials National Cancer Institute
Sheila Prindiville, MD, MPH Director Coordinating Center for Clinical Trials National Cancer Institute NCI and VA Interagency Group to Accelerate Trials Enrollment (NAVIGATE) Sheila A. Prindiville, M.D.,
More informationConfronting the Complexity of Cancer
AACR-NCI Conference on Systems Biology February 27-March 2, 2011 Hyatt Regency La Jolla, San Diego, CA Sunday, February 27 6:00 p.m. - 7:00 p.m. Keynote Session Use of bionetworks to build better maps
More informationSWOG Plenary I Translational Medicine Science as the Foundation for Rapid and Meaningful Advances in Oncology
SWOG Plenary I Translational Medicine Science as the Foundation for Rapid and Meaningful Advances in Oncology Lee M. Ellis, MD SWOG Vice Chair, Translational Medicine Departments of Surgical Oncology and
More informationUpdate on the NCI Cancer Centers Program Henry P. Ciolino, Ph.D. Director, Office of Cancer Centers
Update on the NCI Cancer Centers Program Henry P. Ciolino, Ph.D. Director, Office of Cancer Centers April 30, 2017 History of the CCSG Funding Opportunity Announcement What hasn t changed What has changed
More informationSpontaneous canine malignancies: Models for precision cancer medicine
National Cancer Institute Spontaneous canine malignancies: Models for precision cancer medicine Amy K. LeBlanc, DVM DACVIM (Oncology) Director, NCI Comparative Oncology Program NIH/NCI Center for Cancer
More informationPredicting outcome from cancer data
Predicting outcome from cancer data Jeffrey Chuang The Jackson Laboratory for Genomic Medicine Drowning in data, thirsting for knowledge 2 Clinical outcome across cancer types TCGA Cancer types 5-year
More informationClinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer
Clinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer Questions Answered by Andrea Apolo, MD is a Lasker Clinical Research Scholar and tenure-track
More informationImpressions of a New NCI Director: Big Data
Impressions of a New NCI Director: Big Data Norman E. Sharpless, M.D. Cancer Informatics for Cancer Centers April 3, 2018 www.cancer.gov www.cancer.gov/espanol October 17, 2018 NCI: Leading the National
More informationVISION» FOCUS DISCOVERY» CREATION
The Women s Health Research Institute at Northwestern University is turning possibility into reality. The possibility that we can improve women s health by requiring that all research studies put greater
More informationUS Opportunities at the Intersection of Physical and Life Sciences
US Opportunities at the Intersection of Physical and Life Sciences Jonathan Franca Koh Program Manager Physical Sciences Oncology Centers (PS OC) Program, Office of Physical Sciences Oncology (OPSO), CSSI,
More informationNCI, Prevention, and Screening
NCI, Prevention, and Screening Doug Lowy, M.D. Acting Director, National Cancer Institute, NIH AACR Cancer Prevention Summit February 3, 2016 Outline of Presentation Cancer mortality trends NCI budget
More informationBIMM134 The Biology of Cancer Winter 2019
BIMM134 The Biology of Cancer Winter 2019 Lectures: Center Hall Room 119 Tuesdays/Thursdays; 3:30 4:50 PM January 9 March 15 Discussion Sections: Wednesday 12-1 CSB 001 Friday 12-1 CSB 001 Instructor:
More informationIdentifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They?
Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They? Dubovenko Alexey Discovery Product Manager Sonia Novikova Solution Scientist September 2018 2 Non-Small Cell Lung Cancer
More information2017 CURE - Sleep and Epilepsy Award Request for Applications (RFA) with LOI & Full Proposal Guidelines
2017 CURE - Sleep and Epilepsy Award Request for Applications (RFA) with LOI & Full Proposal Guidelines About CURE CURE s mission is to cure epilepsy, transforming and saving millions of lives. We identify
More informationAdvancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships
The National Academies of SCIENCES ENGINEERING MEDICINE Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships Leadership The NIH Pain Consortium Mission
More informationPROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund
PROGRESS UPDATE Evan T. Mandeville DIPG Research Fund December 2018 EXECUTIVE SUMMARY As a top-ranked pediatric cancer center, Dana-Farber Cancer Institute combines first-rate patient care with groundbreaking
More informationThe Cancer Moonshot ECCO2018 September 7, 2018
The Cancer Moonshot ECCO2018 September 7, 2018 Dinah S. Singer, Ph.D. Deputy Director National Cancer Institute, NIH www.cancer.gov/moonshot Goals of the Cancer Moonshot Accelerate progress in cancer,
More informationCAR T Cell Therapies Workshop
CAR T Cell Therapies Workshop May 15, 2018 Hilton Chicago Continental B Chicago Table of Contents CAR T Cell Therapies Workshop Supporters... p 2 Committee Listing... p 3 Faculty Listing... p 3 Faculty
More informationImmediate Past President National Medical Association
Improved Survival but Continued Disparities in Cancer: The 1971 National Cancer Act through Moonshot 2017 Edith Peterson Mitchell, MD, FACP, FCPP Clinical Professor of Medicine and Medical Oncology Department
More informationWhen fighting lung cancer, every cancer is personal 18 November 2014, by Sylvia Wrobel
When fighting lung cancer, every cancer is personal 18 November 2014, by Sylvia Wrobel lung cancer clinical trials underway at Winship, thanks to Winship's status as Georgia's only National Cancer Institute-designated
More information8/17/2011. FY 2010 President s Budget Request Total NIH Budget Authority $31.0 Billion
NIH OD NCI NEI NHLBI NHGRI NIA NIAAA NIAID NIAMS NIBIB NICHD NIDCD NIDCR NIDDK NIDA NIEHS NIGMS NIMH NINDS NINR NLM CIT CSR FIC NCCAM NCMHD NCRR FY 2010 President s Budget Request Total NIH Budget Authority
More information4th Central Eastern European Symposium on Free Nucleic Acids in Non-Invasive Prenatal Diagnosis Split, May Second Announcement
Josip Juraj Strossmayer University of Osijek FACULTY OF MEDICINE OSIJEK 4th Central Eastern European Symposium on Free Nucleic Acids in Non-Invasive Prenatal Diagnosis Split, 25-26 May 2016 Second Announcement
More informationEpigenetic programming in chronic lymphocytic leukemia
Epigenetic programming in chronic lymphocytic leukemia Christopher Oakes 10 th Canadian CLL Research Meeting September 18-19 th, 2014 Epigenetics and DNA methylation programming in normal and tumor cells:
More informationGene x Environment x Development Interactions (GEDI) NIDA Strategic Planning Workgroup. April 17, Organizational Meeting
Gene x Environment x Development Interactions (GEDI) NIDA Strategic Planning Workgroup April 17, 2015 Organizational Meeting Co-Chairs: Naimah Weinberg, M.D. (NIDA) Jonathan Pollock, Ph.D. (NIDA) Slide
More informationNew NCCIH Funding Opportunities for Mind and Body Clinical Trials. April 24, 2017
New NCCIH Funding Opportunities for Mind and Body Clinical Trials April 24, 2017 Introductions Wendy Weber, N.D., Ph.D., M.P.H. Branch Chief, Clinical Research in Complementary and Integrative Health Branch,
More informationBRP update from the NCI Acting Director
BRP update from the NCI Acting Director Douglas R. Lowy Acting Director, National Cancer Institute National Institutes of Health BRP Virtual Meeting May 9, 2017 NCI APPROPRIATIONS 2013-2017 (in billions)
More informationORIEN NOVA TEAM SCIENCE AWARD
ORIEN NOVA TEAM SCIENCE AWARD CALL FOR LETTERS OF INTENT BACKGROUND: The Oncology Research Information Exchange Network (ORIEN) is a unique alliance to integrate data sharing and collaborative learning
More informationCertificate of Advanced Studies in Personalized Molecular Oncology
Certificate of Advanced Studies in Personalized Molecular Oncology Certificate of Advanced Studies (CAS) in Personalized Molecular Oncology Overview Cutting-edge technologies, like next-generation-sequencing
More informationJohn Templeton Foundation
John Templeton Foundation In keeping with Sir John Templeton's intent, his Foundation serves as a philanthropic catalyst for research and discoveries relating to what scientists and philosophers call the
More informationPROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund
PROGRESS UPDATE Evan T. Mandeville DIPG Research Fund October 2017 EXECUTIVE SUMMARY Investigators at Dana-Farber Cancer Institute are global leaders in pediatric brain tumor research and patient care,
More informationCONTRACTING ORGANIZATION: Joan & Sanford I. Weill Medical College of Cornell University New York, NY 10065
AWARD NUMBER: W81XWH-14-1-0263 TITLE: Early Detection of NSCLC Using Stromal Markers in Peripheral Blood PRINCIPAL INVESTIGATOR: Dingcheng Gao CONTRACTING ORGANIZATION: Joan & Sanford I. Weill Medical
More informationAffiliate Highlight: Fellow Gains New Perspective on the Impact of Breast Cancer Research
Page 1 of 5 Share Past Issues Komen Research Updates 2013 ASCO Annual Meeting, Exciting Research Grantee Announcements, and more! Table of Contents: Affiliate Highlight: Fellow Gains New Perspective on
More informationWeekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)
Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts 08-24-2018 Table of Contents (TOC) Notices Notice of Webinar for PAR 18 307 "Developing Interventions for Health Enhancing
More informationNeutral evolution in colorectal cancer, how can we distinguish functional from non-functional variation?
in partnership with Neutral evolution in colorectal cancer, how can we distinguish functional from non-functional variation? Andrea Sottoriva Group Leader, Evolutionary Genomics and Modelling Group Centre
More informationConference Theme. Pre-Conference Events
Conference Theme Pediatric cancers are the leading cause of disease-related death in children however, childhood cancers possess a distinct etiology defined as a rare disease when contrasted with the adult
More informationNIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH
NIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH AAMC Webinar November 8, 2018 Walter J. Koroshetz, MD Director, National Institute of Neurological
More informationWeekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)
Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts 12-15-2017 Table of Contents (TOC) All NIH Funding Opportunities and Notices Notices Additional Short-Term Administrative
More informationVaccines and Immunization research & development
32 nd International conference on Vaccines and Immunization research & development 0 http://vaccines.global-summit.com/america/ Invitation Dear Attendees, We are glad to announce the 32 nd International
More informationPROGRESS UPDATE. Lauren s First and Goal
PROGRESS UPDATE Lauren s First and Goal August 2015 EXECUTIVE SUMMARY The Pediatric Low-Grade Astrocytoma (PLGA) Program at Dana-Farber Cancer Institute is committed to improving outcomes for young patients
More informationNIDDK: Priorities and Perspectives. NIDDK: Support of Fatty Liver Disease Research. National Institutes of Health $30,142,653,000
NIDDK: Priorities and Perspectives Edward Doo Program Director Liver Diseases Research Branch, NIDDK National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health STOPNASH
More informationPROGRESS UPDATE. The Prayers From Maria Foundation
PROGRESS UPDATE The Prayers From Maria Foundation August 2016 EXECUTIVE SUMMARY Dana-Farber Cancer Institute is a global leader in discovery science and patient care for pediatric brain tumors, including
More informationNewsletter. August 7, Visit
Share: Tweet Newsletter August 7, 2013 Jump to a Topic: Upcoming Events Funding Opportunities Conferences and Meetings Announcements Check out our new website! We are excited to announce the launching
More informationBreast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data
Breast cancer Inferring Transcriptional Module from Breast Cancer Profile Data Breast Cancer and Targeted Therapy Microarray Profile Data Inferring Transcriptional Module Methods CSC 177 Data Warehousing
More informationDEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014
DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014 Karen Arts, Director Canadian Cancer Clinical Trial Network (3CTN) Chair of the Board of N2 Administrative Office: Lawson
More informationOn Human Natures: Psychological Science in the Service of Theology Application Information Packet
On Human Natures: Psychological Science in the Service of Theology Application Information Packet A program to support science-engaged theology, training theologians in psychological science, to make new
More informationRequest for Applications Basic, Clinical and Population Science Pilot Awards
Request for Applications Basic, Clinical and Population Science Pilot Awards Spring, 2013 SUMMARY The University of Wisconsin Carbone Cancer Center (UWCCC) is an NCI-designated Comprehensive Cancer Center
More informationPopulation Science and Community Engagement
Population Science and Community Engagement Elizabeth Shenkman, PhD Professor and Chair Health Outcomes & Policy Co-Director, OneFlorida Clinical Research Consortium 1 Key Initiatives Cancer Prevention
More information2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme
2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme Thursday 1 st December 2016 09.15am 10.00am Registration and Refreshments 10.15am 10.30am Welcome 10.30am 11.15am Opening
More informationCancer Moonshot Blue Ribbon Panel Report.
Cancer Moonshot Blue Ribbon Panel Report www.cancer.gov/brp Goals of the Cancer Moonshot Accelerate progress in cancer, including prevention & screening From cutting edge basic research to wider uptake
More informationMelanoma Research Foundation Request for Proposals (RFP) 2017
Melanoma Research Foundation Request for Proposals (RFP) 2017 RESEARCH OVERVIEW: The Melanoma Research Foundation (MRF) is committed to advancing research across the spectrum of melanoma from prevention
More informationCLL Sample! Clinical Trials! Accrual, tracking,! correlative studies! Immunophenotyping! Surface & intracellular! ZAP-70/CD38! prognosis!
ZAP-70/CD38! prognosis! IGHV! Mutational status! prognosis! Cytogenetics! FISH! karyotype! Cellular Kinetics! B-cell turnover rates! CD38/Ki67/CXCR4! Buccal swabbs! Germline DNA! Genetics studies! Immunophenotyping!
More informationImproving the Mental Health and Wellbeing of Adolescents and Young Adults
Spring 2017 Update Improving the Mental Health and Wellbeing of Adolescents and Young Adults In this update à Our Center is expanding! Meet our new team members. à Bringing the headspace model to the Bay
More informationNature Immunology: doi: /ni Supplementary Figure 1. RNA-Seq analysis of CD8 + TILs and N-TILs.
Supplementary Figure 1 RNA-Seq analysis of CD8 + TILs and N-TILs. (a) Schematic representation of the tumor and cell types used for the study. HNSCC, head and neck squamous cell cancer; NSCLC, non-small
More informationNIH-NCI Newsletter. National Cancer Institute Population-based Research to Optimize the Screening Process (PROSPR) (UM1) RFA-CA
NIH-NCI Newsletter Population-based Research to Optimize the Screening Process (PROSPR) (UM1) RFA-CA-16-016 Application Due Date: February 9, 2017 "http://grants.nih.gov/grants/guide/rfa-files/rfa-ca-16-016.html"
More informationAdvances in Breast Cancer Research: Genetics, Biology, and Clinical Applications
An AACR Special Conference on October 12-15, 2011 The Fairmont San Francisco San Francisco, CA Wednesday, October 12 7:00 p.m.-8:00 p.m. Opening Keynote Address Chairperson: Jeffrey M. Rosen, Baylor College
More informationBroad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor suppressor genes
Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor suppressor genes Kaifu Chen 1,2,3,4,5,10, Zhong Chen 6,10, Dayong Wu 6, Lili Zhang 7, Xueqiu Lin 1,2,8,
More informationRequest for Applications Post-Traumatic Stress Disorder GWAS
Request for Applications Post-Traumatic Stress Disorder GWAS PROGRAM OVERVIEW Cohen Veterans Bioscience & The Stanley Center for Psychiatric Research at the Broad Institute Collaboration are supporting
More informationSerum C8 By Estradiol Levels In Females <10 Years Of Age
Serum C8 By Levels In Females
More informationNobel Laureate Harold Varmus Joins Weill Cornell Medical College to Advance Cancer Research
Contact: Weill Cornell Medical College New York Genome Center Sarah Smith Sara Ghazaii sas2072@med.cornell.edu sghazaii@nygenome.org 646-317-7401 646-977-7070 Nobel Laureate Harold Varmus Joins Weill Cornell
More informationEmerging Tissue and Serum Markers
Emerging Tissue and Serum Markers for Immune Checkpoint Inhibitors Kyong Hwa Park MD, PhD Medical Oncology Korea University College of Medicine Contents Immune checkpoint inhibitors in clinical practice
More informationTheme: Prospects and Development of Prophylactic & Therapeutic Vaccines.
conferenceseries.com Tentative Program 32 nd International conference on Vaccines and Immunization R&D, B2B November 9-10, 2018 Atlanta, Georgia, USA Theme: Prospects and Development of Prophylactic &
More information2015 AP Biology Unit #4 Quiz 1 Cell Communication, Cancer and The Cell Cycle Week of November
Name: Class: Date: 2015 AP Biology Unit #4 Quiz 1 Cell Communication, Cancer and The Cell Cycle Week of 16-20 November Multiple Choice Identify the choice that best completes the statement or answers the
More informationShould novel molecular therapies replace old knowledge of clinical tumor biology?
Should novel molecular therapies replace old knowledge of clinical tumor biology? Danai Daliani, M.D. Director, 1 st Oncology Clinic Euroclinic of Athens Cancer Treatments Localized disease Surgery XRT
More informationNew technologies for studying human immunity. Lisa Wagar Postdoctoral fellow, Mark Davis lab Stanford University School of Medicine
New technologies for studying human immunity Lisa Wagar Postdoctoral fellow, Mark Davis lab Stanford University School of Medicine New strategies: Human immunology is ideal for a systems approach We have
More informationFuture Faces of Physics Award Proposal
Future Faces of Physics Award Proposal Project Proposal Title Name of School The Signs of Physics University of Central Arkansas SPS Chapter Number 1059 Total Amount Requested $300.00 Abstract The Society
More informationProgress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:
SU2C -Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant: DNA Repair Therapies for Ovarian Cancer AND SU2C Catalyst Merck-Supported Supplemental
More informationImmune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment
Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment 1 Introductions Peter Langecker, MD, PhD Executive Medical Director, Global Oncology Clinipace Worldwide Mark Shapiro Vice President
More informationThe Alzheimer s Disease Centers Program: updates
The Alzheimer s Disease Centers Program: updates Nina Silverberg, Ph.D Director, Alzheimer s Disease Centers Program, NIA Presented at Directors Meeting, October 20, 2018, Atlanta, GA Polleverywhere Feedback
More informationMelanoma Research Foundation Request for Proposals (RFP) 2019
Melanoma Research Foundation Request for Proposals (RFP) 2019 RESEARCH OVERVIEW: The Melanoma Research Foundation (MRF) is committed to advancing research across the spectrum of melanoma from prevention
More informationCancer Biology Annual Retreat
Cancer Biology Annual Retreat Kiawah Island, South Carolina October 25-27, 2015 Agenda Sunday, October 25 9:00 am 12:00 pm Executive Committee/Board Meeting 2:00 pm 7:00 pm Welcome Lounge & Registration
More informationWeekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)
Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts 01-12-2018 Table of Contents (TOC) All NIH Funding Opportunities and Notices Notices NIH Operates Under a Continuing Resolution
More informationCOST ACTION CA IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN)
COST ACTION CA17118 - IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN) Working group 1 participant duties - Align with the scientific
More informationKansas Respiratory Care Society January 8, 2016 Salina Regional Health Center Salina, KS
Kansas Respiratory Care Society January 8, 2016 Salina Regional Health Center Salina, KS Attending Terri Lesser, Monica Baden, Don Richards, Jessica Callaway, Charity Clark, Glenn Tammen, Jerry Houchin,
More informationAgenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center. June 22-23, 2018
Agenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center June 22-23, 2018 Note: ** Indicates the activity has been approved for AMA PRA Category 1 Credit jointly provided
More informationThe 100,000 Genomes Project
The 100,000 Genomes Project Dr Matina Prapa, Scientific co ordinator Genomics England Clinical Interpretation Partnership William Harvey Research Institute Queen Mary University of London Genomics England
More informationAccelerating Translation at Dana-Farber Cancer Institute*
Accelerating Translation at Dana-Farber Cancer Institute* *and our partner institutions February 12, 2013 Edward J Benz JR, MD Dana Farber Cancer Institute 1 2 Academic Structure All Dana-Farber faculty
More informationDahshu Virtual Journal Club
Dahshu Virtual Journal Club DahShu is a nonprofit organization with the mission of promoting research and education in data science For more information, visit: http://www.dahshu.org/ Questions? Contact
More informationParkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist and Movement Disorders Specialist as Chief Medical Officer
Press Release For Immediate Release October 30, 2017 Contact: Chris Di Salvo Mobile: (408) 506-0455 E-mail: profeff@aol.com Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist
More informationCell Communication. Chapter 11. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for
Chapter 11 Cell Communication PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp
More informationCOST ACTION CA IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN)
COST ACTION CA17118 - IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN) Working group 1 management committee duties - Contribute
More informationBRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER
SCIENTIFIC ADVISORY BRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER Researchers from A*STAR s SBIC have discovered how changes in BCAA metabolism influence the development
More informationThe Breast Cancer Research Foundation
Advances in Experimental Medicine and Biology The Breast Cancer Research Foundation Larry Norton, MD Medical Director, Evelyn H. Lauder Breast Center Memorial Sloan Kettering Cancer Center Professor of
More informationIntegrating Geriatrics into the Specialties of Internal Medicine. Workshop on Wound Repair and Healing in Older Adults February 20-21, 2014
Integrating Geriatrics into the Specialties of Internal Medicine Workshop on Wound Repair and Healing in Older Adults February 20-21, 2014 Funded by grants by The John A Hartford Foundation and NIA to
More informationMelanoma Research Alliance-Pfizer Academic-Industry Partnership Awards
Melanoma Research Alliance-Pfizer Academic-Industry Partnership Awards Wendy K.D. Selig, President & CEO, MRA Julia Perkins, M.D. Medical Director, Oncology, Pfizer Melanoma Research Alliance Mission:
More informationBases for Immunotherapy in Multiple Myeloma
Bases for Immunotherapy in Multiple Myeloma Paola Neri, MD, PhD Associate Professor of Medicine University of Calgary, Arnie Charbonneau Cancer Institute Disclosures Paola Neri MD, PhD Grants/research
More informationTREAT-NMD Partner Newsletter No th June 2007 and Club of Interest Newsletter No. 11
TREAT-NMD Partner Newsletter No. 17 29 th June 2007 and Club of Interest Newsletter No. 11 Welcome to the eleventh newsletter for the TREAT-NMD Club of Interest. This week s edition features a report on
More informationCourse Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins, Ph.D., The Houston Methodist Research Institute
Saturday, August 20 25 th ANNUAL SHORT COURSE ON EXPERIMENTAL MODELS OF HUMAN CANCER August 20-28, 2016 Course Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins,
More information3D-Tissue Microsystems for Tumor Microenvironments Designs for Basic and Translational Research
3D-Tissue Microsystems for Tumor Microenvironments Designs for Basic and Translational Research Michael Phelan Biostatistics Shared Resource Chao Family Comprehensive Cancer Center UC, Irvine School of
More informationHepatitis B Foundation (HBF) Meetings with National Institutes for Health (NIH) On Research Opportunities For Finding A Cure For HBV March 12, 2018
Hepatitis B Foundation (HBF) Meetings with National Institutes for Health (NIH) On Research Opportunities For Finding A Cure For HBV March 12, 2018 Carol L. Brosgart, MD Member, Board of Directors, Hepatitis
More informationThe Intersection of Nutrition and Genetics. Beverly K. Jordan, MPA Director of Community Outreach
The Intersection of Nutrition and Genetics Beverly K. Jordan, MPA Director of Community Outreach The Intersection of Nutrition and Genetics Objectives Learn about the work happening at the new UNC-Chapel
More informationNCRI Biomarkers & Imaging CSG Cell-free DNA workshop
NCRI Biomarkers & Imaging CSG Cell-free DNA workshop Workshop Report Christie Education Centre, Manchester 30th January 2014 Sponsored by Workshop summary 86 delegates from a variety of specialities attended
More informationSingle-Cell Sequencing in Cancer. Peter A. Sims, Columbia University G4500: Cellular & Molecular Biology of Cancer October 22, 2018
Single-Cell Sequencing in Cancer Peter A. Sims, Columbia University G4500: Cellular & Molecular Biology of Cancer October 22, 2018 Lecture will focus on technology for and applications of single-cell RNA-seq
More information